[HTML][HTML] A proteomic signature for dementia with Lewy bodies
SE O'Bryant, TJ Ferman, F Zhang, J Hall… - Alzheimer's & Dementia …, 2019 - Elsevier
Introduction We sought to determine if a proteomic profile approach developed to detect
Alzheimer's disease would distinguish patients with Lewy body disease from normal …
Alzheimer's disease would distinguish patients with Lewy body disease from normal …
A proteomic signature for dementia with Lewy bodies
SE O'Bryant, TJ Ferman, F Zhang, J Hall… - Alzheimer's & …, 2019 - Wiley Online Library
Introduction We sought to determine if a proteomic profile approach developed to detect
Alzheimer's disease would distinguish patients with Lewy body disease from normal …
Alzheimer's disease would distinguish patients with Lewy body disease from normal …
A proteomic signature for dementia with Lewy bodies.
SE O'Bryant, TJ Ferman, F Zhang, J Hall… - Alzheimer's & …, 2019 - europepmc.org
Methods Stored plasma samples were obtained from 145 patients (DLB n= 57, PD without
dementia n= 32, normal controls n= 56) enrolled from patients seen in the Behavioral …
dementia n= 32, normal controls n= 56) enrolled from patients seen in the Behavioral …
A proteomic signature for dementia with Lewy bodies
SE O'Bryant, TJ Ferman, F Zhang… - Alzheimer's & …, 2019 - pubmed.ncbi.nlm.nih.gov
Introduction We sought to determine if a proteomic profile approach developed to detect
Alzheimer's disease would distinguish patients with Lewy body disease from normal …
Alzheimer's disease would distinguish patients with Lewy body disease from normal …
[PDF][PDF] A proteomic signature for dementia with Lewy bodies
SE O'Bryant, TJ Ferman, F Zhang, JR Hall, O Pedraza… - 2019 - unthsc-ir.tdl.org
Introduction: We sought to determine if a proteomic profile approach developed to detect
Alzheimer's disease would distinguish patients with Lewy body disease from normal …
Alzheimer's disease would distinguish patients with Lewy body disease from normal …
[HTML][HTML] A proteomic signature for dementia with Lewy bodies
SE O'Bryant, TJ Ferman, F Zhang, J Hall… - … & Disease Monitoring, 2019 - ncbi.nlm.nih.gov
Methods Stored plasma samples were obtained from 145 patients (DLB n= 57, PD without
dementia n= 32, normal controls n= 56) enrolled from patients seen in the Behavioral …
dementia n= 32, normal controls n= 56) enrolled from patients seen in the Behavioral …
A proteomic signature for dementia with Lewy bodies
SE O'Bryant, TJ Ferman, F Zhang… - Alzheimer's and …, 2019 - mayoclinic.pure.elsevier.com
Introduction: We sought to determine if a proteomic profile approach developed to detect
Alzheimer's disease would distinguish patients with Lewy body disease from normal …
Alzheimer's disease would distinguish patients with Lewy body disease from normal …
A proteomic signature for dementia with Lewy bodies
SE O'Bryant, TJ Ferman, F Zhang… - Alzheimer's and …, 2019 - mayoclinic.elsevierpure.com
Introduction: We sought to determine if a proteomic profile approach developed to detect
Alzheimer's disease would distinguish patients with Lewy body disease from normal …
Alzheimer's disease would distinguish patients with Lewy body disease from normal …
A proteomic signature for dementia with Lewy bodies.
SE O'Bryant, TJ Ferman, F Zhang, J Hall… - Alzheimer's & …, 2019 - europepmc.org
Methods Stored plasma samples were obtained from 145 patients (DLB n= 57, PD without
dementia n= 32, normal controls n= 56) enrolled from patients seen in the Behavioral …
dementia n= 32, normal controls n= 56) enrolled from patients seen in the Behavioral …